Cargando…
Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2
Human carboxylesterase 2 (CES2), one of the most abundant hydrolases distributed in the small intestine, has been validated as a key therapeutic target to ameliorate the intestinal toxicity caused by irinotecan. This study aims to discover efficacious CES2 inhibitors from natural products and to cha...
Autores principales: | Song, Yun-Qing, He, Rong-Jing, Pu, Dan, Guan, Xiao-Qing, Shi, Jin-Hui, Li, Yao-Guang, Hou, Jie, Jia, Shou-Ning, Qin, Wei-Wei, Fang, Sheng-Quan, Ge, Guang-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167799/ https://www.ncbi.nlm.nih.gov/pubmed/34084136 http://dx.doi.org/10.3389/fphar.2021.655659 |
Ejemplares similares
-
Potent Inhibition of Human Cytochrome P450 3A4 by Biflavone Components from Ginkgo Biloba and Selaginella Tamariscina
por: Wang, Bo, et al.
Publicado: (2022) -
Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1
por: Pang, Hui-Lin, et al.
Publicado: (2022) -
Structure-Activity Relationships of Pentacyclic Triterpenoids as Potent and Selective Inhibitors against Human Carboxylesterase 1
por: Zou, Li-Wei, et al.
Publicado: (2017) -
Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer’s disease
por: Liu, Li-Wei, et al.
Publicado: (2022) -
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
por: Nowak, Anna, et al.
Publicado: (2021)